It has been previously reported that styrl-benzoxazole derivatives do not show binding to NFTs in AD brain sections [26]; however, compounds with a 15–18 Å of pi-electron-conjugated backbone show a high affinity to pathological tau [33]. Here, MAPT is linked to Alzheimer disease.